Prognostic factors in Epstein-Barr virus-associated stage I–III gastric carcinoma: Implications for a unique type of carcinogenesis
Authors:
Open Access
- 5 June 2014
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 32 (2) , 530-538
Abstract
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) has distinct clinicopathological features. However, the prognostic factors remain unclear, particularly in UICC/AJCC stage I-III cancer. We retrospectively enrolled 1,020 patients with stage I-III gastric cancer that received radical gastrectomy with lymphadenectomy. Formalin-fixed, paraffin‑embedded surgical specimens were retrieved to construct tissue microarrays. EBV positivity was identified by in situ hybridization with EBV-encoded small RNA, and the histological classification was reviewed. Fifty-two cases of EBVaGC were identified, exhibiting a male predominance (p=0.003), a higher prevalence in stump cancer (p5 cm, non-lymphoepithelioma-like carcinoma (LELC), or a lymph node ratio >0.15 had a worse overall survival (hazard ratio 2.884, 12.178 and 19.352; p=0.027, 0.005 and <0.0001, respectively). The depth of tumor invasion and the number of lymph node metastases did not reach statistical significance (p=0.834 and 0.833, respectively). These prognostic factors, tumor size, LELC classification and lymph node ratio, may reflect a unique type of carcinogenesis of EBVaGC and may be considered when selecting high-risk patients for adjuvant treatment.Keywords
This publication has 32 references indexed in Scilit:
- Epstein-Barr virus-associated gastric carcinomaPathology - Research and Practice, 2011
- Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus–Associated Gastric CarcinomaGastroenterology, 2010
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic LocationGastroenterology, 2009
- Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Carcinoma Patients Receiving Adjuvant Chemotherapy and Is Not Associated with EBV InfectionClinical Cancer Research, 2008
- Epstein-Barr virus–associated epithelial and mesenchymal neoplasmsHuman Pathology, 2008
- Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node MetastasesAmerican Journal of Surgical Pathology, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Epstein–Barr virus: 40 years onNature Reviews Cancer, 2004
- EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node InvolvementJournal of Clinical Oncology, 2004
- Gastric carcinoma with lymphoid stroma.Its morphologic characteristics and prognostic correlationsCancer, 1976